Evaluation of the knowledge about next-generation therapies among the Spanish-speaking population
Abstract
Introduction: When it comes to innovative treatments, there is an imperative need to clarify misconceptions and strengthen basic notions in order to enhance patient participation in research. Objectives: To analyse the level of knowledge of the general population regarding genetic and cell therapies. Methodology: The study was performed through an online survey. Results: The survey was completed by 518 people and several gaps were detected, such as target diseases for these treatments, side effects or concepts like ‘vectors’ or ‘mutations’. The respondents highlighted as most appropriate formats conferences given by a professional in the field, videos or infographics. The Internet was the preferred source of information, particularly specialized science media and websites of official institutions. Conclusion: We propose an educational campaign comprising of a series of talks in a blended format, led by experts with both a science and communication background. We also recommend the co-design of a collection of materials disseminated through institutional websites, social networks or science specialized media.
Downloads
References
Aiyegbusi, O. L., Macpherson, K., Elston, L., Myles, S., Washington, J, Sungum, N., … Calvert, M. J. (2020). Patient and public perspectives on cell and gene therapies: a systematic review. Nature Communications, 11, 6265. https://doi.org/10.1038/ s41467-020-20096-1
Baldovino, S., Taruscio, D., & Roccatello, D. (2016). Rare diseases in Europe: from a wide to a local perspective. Israel Medical Association Journal, 18(6), 359-363.
Bick, D., Jones, D., Taylor, S. L., Taft, R. J., & Belmont, J. (2019). Case for genome sequencing in infants and children with rare, undiagnosed or genetic diseases. Journal of Medical Genetics, 56, 783-791. doi:10.1136/jmedgenet-2019-106111
Condit, C. M., Dubriwny, T., Lynch, J., & Parrott, R. (2004). Lay people's understanding of and preference against the word “mutation”. American Journal of Medical Genetics, 130A (3), 245-250. doi: 10.1002/ ajmg.a.30264
Delhove, J., Osenk, I, Prichard, I., & Donelley, M. (2020). Public acceptability of gene therapy and gene editing for human use: a systematic review. Human Gene Therapy, 31, 20-46. doi: 10.1089/hum.2019.197
Department for Business, Energy and Industrial Strategy. (2019). Public attitudes to science 2019. UK Government. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_ data/file/905466/public-attitudes-to-science-2019.pdf
Fundación Española para la Ciencia y la Tecnología. (2020). 10 ª Encuesta de la Percepción Social de la Ciencia y la Tecnología 2020. https://www.fecyt.es/sites/default/files/users/user378/percepcion_social_de_la_ciencia_y_la_tecnologia_2020_informe_ completo_1.pdf
Gottweis, H. (2002). Gene therapy and the public: a matter of trust. Gene Therapy, 9, 667-669. doi: 10.1038/ sj.gt.3301752
Institut de Recerca Sant Joan de Déu (2020, April 2). Terapia celular y terapia génica: ¿dos grandes desconocidas? https://www.irsjd.org/es/actualidad/ noticias/717/terapia-celular-y-terapia-genica-dos-grandes-desconocidas
Institut de Recerca Sant Joan de Déu. (2020, November 30). ¿Te gustaría participar en Rare Commons? Ahora puedes hacerlo a través de una pequeña encuesta. Queremos saber cuál es el [Tweet] Twitter. https://twitter.com/IRSJD_info/ status/1333406657175560193
Instituto Nacional de Estadística. (2020). Encuesta sobre Equipamiento y Uso de Tecnologías de Información y Comunicación en los Hogares 2020. https://www.ine.es/prensa/tich_2020.pdf
Kowalczyk, N., & Draper, L.J. (2012). Trends in patient information preferences and acquisition. Radiologic Technology, 83(4), 316-324.
Li, H. O., Bailey, A., Huynh, D., & Chan, J. (2020). YouTube as a source of information on COVID-19: a pandemic of misinformation? BMJ Global Health, 5 (5), e002604. doi: 10.1136/bmjgh-2020-002604
Litzkendorf, S., Frank, M., Babac, A., Rosenfeldt, D., Schauer, F., Hartz, T., & Graf von der Schulenburg, J.M. (2020). Use and importance of different information sources among patients with rare diseases and their relatives over time: a qualitative study. BMC Public Health, 20 (1), 860. doi: 10.1186/s12889-020-08926- 9
Motoki, K., Saito, T, & Takano, Y. (2021). Scientific literacy linked to attitudes toward COVID-19 vaccinations: a pre-registered study. Frontiers in Communication, 6, 707391. doi: 10.3389/fcomm.2021.707391
Rodino-Klapac, L. R., Chicoine, L. G., Kaspar, B. K., Mendell, J.R. (2007). Gene therapy for Duchenne muscular dystrophy: expectations and challenges. Archives of Neurology, 64 (9), 1236 -1241. doi:10.1001/archneur.64.9.1236
Rodríguez-González, A. M. (2021). Educación para la salud, prevención y promoción comunitaria a través de la página de Facebook de salud de atención primaria. Revista Española de Comunicación en Salud, 12 (1), 58-66. https://doi.org/10.20318/recs.2021.5307
Stewart, M. A. (1995). Effective physician-patient communication and health outcomes: a review. Canadian Medical Association Journal, 152 (9), 1423- 1433.
Share4Rare. (2020, May 8). Comprender cómo se desarrolla una terapia innovadora para una #EnfermedadRara proporciona a los #pacientes una imagen global de su [Tweet] Twitter. https://twitter. com/Share4Rare_es/status/1258702155759988736
Świątoniowska-Lonc, N. A., Sławuta, A., Dudek, K., Jankowska, K., & Jankowska-Polańska, B. K. (2020). The impact of health education on treatment outcomes in heart failure patients. Advances in Clinical Experimental Medicine, 29 (4), 481-492. doi: 10.17219/acem/115079
Syding, L. A., Nickl, P., Kasparek, P., & Sedlacek, R. (2020). CRISPR/Cas9 epigenome editing potential for rare imprinting diseases: a review. CELLS, 9 (4), 993. doi: 10.3390/cells9040993
Urarte, E. (2020, October 7) Analizar los conocimientos de la población sobre terapia celular y genética para crear materiales educativos personalizados para la ciudadanía. Share4Rare. https://www.share4rare.org/ es/news/analizar-los-conocimientos-de-la-poblacion-sobre-terapia-celular-y-genetica-para-crear
Zhang, X., Weizhen, X., Liu, L., & Wang, L. (2019). Improvement in quality of life and activities of daily living in patients with liver cirrhosis with the use of health education and patient health empowerment. Medical Science Monitor, 25, 4602-4608. doi: 10.12659/MSM.914487
All articles published in this journal –unless otherwise stated- are distributed under the terms of the Creative Commons Attribution-NoDerives (CC-BY-ND 3.0 ES) Spain 3.0 License, which allows others to copy, distribute and transmit in a public way as long as they credit the author(s), journal and institution that publish these articles, and provided that they are not altered or modified. The complete license can be consulted in: https://creativecommons.org/licenses/by/3.0/es/deed/.es
The copyright belongs to the manuscript’s author just on the basis of creating this work:
- Moral rights are undeniable and inalienable.
- Economic or exploitation rights can be transferred to third parties, as it occurs when articles are published and authors partially or totally transfer their exploitation rights to publishers
Authors can archive their own articles in an institutional repository as long as their publications are cited in this journal.
